The One Fund Boston, MGH and Massachusetts Eye and Ear Infirmary are creating the One Fund Center, a collaboration that will offer ongoing care to those affected by the often invisible, yet persistent, injuries sustained in the Boston Marathon bombings.. Read more.
10/01/14: Delayed introduction to gluten appears not to prevent celiac disease in at-risk infants An study led by investigators at the MGHfC Center for Celiac Research and Treatment finds that neither breastfeeding nor delaying the introduction of gluten-containing foods prevents or delays the development of celiac disease in at-risk children.
9/24/14: Crizotinib treatment effective against ROS1-positive lung cancer Treatment with the targeted therapy drug crizotinib shown to effectively halt the growth of lung tumors driven by rearrangements of the ROS1 gene in MGH-led clinical trial.
9/26/14: Policies of NIH, other funders, have improved data-sharing by life-science investigators Policies put into place by major funding agencies like the National Institutes of Health, and to a lesser extent by scientific journals, appear to be meeting the goal of increasing the sharing of scientific resources among life science investigators.
9/22/14: Mass. General study reveals gene expression patterns in pancreatic circulating tumor cells Analysis of circulating tumor cells in a mouse model of pancreatic cancer identified distinct patterns of gene expression in several groups of CTCs, including significant differences from the primary tumor that may contribute to the ability to generate metastases and prove to be targets for improved treatment of the deadly tumor.
9/16/14: Point-of-care CD4 testing is economically feasible for HIV care in resource-limited areas A study by MGH investigators, working in collaboration with colleagues in Mozambique and South Africa, indicates that routine point-of-care CD4 testing at the time of HIV diagnosis could be cost effective in countries where health care and other resources are severely limited.
9/03/14: Digital mammography system developed at Mass. General Hospital receives FDA approval A digital mammography system developed based on concepts originally tested at MGH has been approved by the U.S. Food and Drug Administration.
Newsletters & Publications
Hotline Each week, MGH Hotline reports important news within the Massachusetts General Hospital community featuring employees and initiatives that focus on bettering the future of clinical care, research and training.
Proto Proto, a magazine that reaches 75,000 thought leaders nationwide, stakes its ground on medicine's leading edge, reporting back from the frontiers of research and practice—exploring breakthroughs, dissecting controversies and opening a forum for informed debate.
Mass General Magazine Mass General Magazine takes you into the heart of the institution, describing ways in which Mass General is leading the way in educating physicians, nurses and other healthcare professionals; in improving the health of local and distant communities; and in establishing best practices and health policy.
09/19/2014: Enterovirus suspected in several Mass. cases
quotes MGHfC physician Bernard Kinane
09/19/2014: Rare Enterovirus Making Its Way to Massachusetts
09/19/2014: ASTRO Quick Take: Induction Gemcitabine/Capecitabine Followed by SABR in Borderline/Locally Advanced Pancreatic Adenocarcinoma
video report with MGH physician Ted Hong
09/19/2014: Denosumab After Teriparatide Boosts Bone-Density Gains
coverage of study led by MGH investigator Benjamin Leder
09/18/2014: Half of Americans still skip yearly flu vaccine
The Boston Globe
coverage quoting MGH physician Laura Riley